Skip Nav Destination
Issues
Editorials
Review
Human Cancer Biology
Persistent Activation of Stat3 Signaling Induces Survivin Gene Expression and Confers Resistance to Apoptosis in Human Breast Cancer Cells
Tanya Gritsko; Ann Williams; James Turkson; Satoshi Kaneko; Tammy Bowman; Mei Huang; Sangkil Nam; Ibrahim Eweis; Nils Diaz; Daniel Sullivan; Sean Yoder; Steve Enkemann; Steven Eschrich; Ji-Hyun Lee; Craig A. Beam; Jin Cheng; Susan Minton; Carlos A. Muro-Cacho; Richard Jove
Activation of Stat3 in Primary Tumors from High-Risk Breast Cancer Patients Is Associated with Elevated Levels of Activated Src and Survivin Expression
Nills Diaz; Susan Minton; Charles Cox; Tammy Bowman; Tanya Gritsko; Roy Garcia; Ibrahim Eweis; Marek Wloch; Sandy Livingston; Ed Seijo; Alan Cantor; Ji-Hyun Lee; Craig A. Beam; Daniel Sullivan; Richard Jove; Carlos A. Muro-Cacho
Vascular Endothelial Growth Factor Messenger RNA Expression Level Is Preserved in Liver Metastases Compared with Corresponding Primary Colorectal Cancer
Hidekazu Kuramochi; Kazuhiko Hayashi; Kazumi Uchida; Satoru Miyakura; Daisuke Shimizu; Daniel Vallböhmer; Seongjin Park; Kathleen D. Danenberg; Ken Takasaki; Peter V. Danenberg
Detection of Wilms' Tumor Antigen–Specific CTL in Tumor-Draining Lymph Nodes of Patients with Early Breast Cancer
Roopinder Gillmore; Shao-An Xue; Angelika Holler; Jaspal Kaeda; Dimitri Hadjiminas; Vourneen Healy; Roberto Dina; Suzanne C. Parry; Ilaria Bellantuono; Yasmeen Ghani; R. Charles Coombes; Jonathan Waxman; Hans J. Stauss
Detection of EGFR Gene Mutation in Lung Cancer by Mutant-Enriched Polymerase Chain Reaction Assay
Hiroaki Asano; Shinichi Toyooka; Masaki Tokumo; Kouichi Ichimura; Keisuke Aoe; Sachio Ito; Kazunori Tsukuda; Mamoru Ouchida; Motoi Aoe; Hideki Katayama; Akio Hiraki; Kazuro Sugi; Katsuyuki Kiura; Hiroshi Date; Nobuyoshi Shimizu
Imaging, Diagnosis, Prognosis
Measurement of Serum Levels of Macrophage Inhibitory Cytokine 1 Combined with Prostate-Specific Antigen Improves Prostate Cancer Diagnosis
David A. Brown; Carsten Stephan; Robyn L. Ward; Mathew Law; Mark Hunter; Asne R. Bauskin; Janaki Amin; Klaus Jung; Eleftherios P. Diamandis; Garret M. Hampton; Pamela J. Russell; Graham G. Giles; Samuel N. Breit
Value of 18F-Fluoro-2-Deoxy-d-Glucose-Positron Emission Tomography/Computed Tomography in Non–Small-Cell Lung Cancer for Prediction of Pathologic Response and Times to Relapse after Neoadjuvant Chemoradiotherapy
Christoph Pöttgen; Sabine Levegrün; Dirk Theegarten; Simone Marnitz; Sara Grehl; Roman Pink; Wilfried Eberhardt; Georgios Stamatis; Thomas Gauler; Gerald Antoch; Andreas Bockisch; Martin Stuschke
Definition of an Immunologic Response Using the Major Histocompatibility Complex Tetramer and Enzyme-Linked Immunospot Assays
Begoña Comin-Anduix; Antonio Gualberto; John A. Glaspy; Elisabeth Seja; Maribel Ontiveros; Deborah L. Reardon; Roberto Renteria; Brigitte Englahner; James S. Economou; Jesus Gomez-Navarro; Antoni Ribas
Expression of Hepatoma-Derived Growth Factor Is Correlated with Lymph Node Metastasis and Prognosis of Gastric Carcinoma
Shinji Yamamoto; Yasuhiko Tomita; Yoshihiko Hoshida; Shuji Takiguchi; Yoshiyuki Fujiwara; Takushi Yasuda; Yuichiro Doki; Kenya Yoshida; Katsuyuki Aozasa; Hideji Nakamura; Morito Monden
Cancer Therapy: Clinical
Cancer Therapy: Preclinical
Anti-CD3 × Anti-Epidermal Growth Factor Receptor (EGFR) Bispecific Antibody Redirects T-Cell Cytolytic Activity to EGFR-Positive Cancers In vitro and in an Animal Model
Ursula Reusch; Magesh Sundaram; Pamela A. Davol; Sarah D. Olson; James B. Davis; Kurt Demel; Julie Nissim; Ritesh Rathore; Paul Y. Liu; Lawrence G. Lum
Motexafin-Gadolinium Taken Up In vitro by at Least 90% of Glioblastoma Cell Nuclei
Gelsomina De Stasio; Deepika Rajesh; Judith M. Ford; Matthew J. Daniels; Robert J. Erhardt; Bradley H. Frazer; Tolek Tyliszczak; Mary K. Gilles; Robert L. Conhaim; Steven P. Howard; John F. Fowler; François Estève; Minesh P. Mehta
Evaluation of the Antitumor Efficacy, Pharmacokinetics, and Pharmacodynamics of the Histone Deacetylase Inhibitor Depsipeptide in Childhood Cancer Models In vivo
Claire Graham; Chandra Tucker; Jeremy Creech; Edward Favours; Catherine A. Billups; Tiebin Liu; Maryam Fouladi; Burgess B. Freeman, III; Clinton F. Stewart; Peter J. Houghton
Antitumor Efficacy of a Combination of CMC-544 (Inotuzumab Ozogamicin), a CD22-Targeted Cytotoxic Immunoconjugate of Calicheamicin, and Rituximab against Non-Hodgkin's B-Cell Lymphoma
John F. DiJoseph; Maureen M. Dougher; Lyka B. Kalyandrug; Douglas C. Armellino; Erwin R. Boghaert; Philip R. Hamann; Justin K. Moran; Nitin K. Damle
Optimizing a Novel Regional Chemotherapeutic Agent against Melanoma: Hyperthermia-Induced Enhancement of Temozolomide Cytotoxicity
Sae Hee Ko; Tomio Ueno; Yasunori Yoshimoto; Jin Soo Yoo; Omar I. Abdel-Wahab; Zeinab Abdel-Wahab; Edward Chu; Scott K. Pruitt; Henry S. Friedman; Mark W. Dewhirst; Douglas S. Tyler
Cancer Prevention
Letter to the Editor
Corrections
Advertisement
